Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis.
Publication/Presentation Date
1-1-1988
Abstract
Posttransfusion alloimmunization to red cell antigens was studied in a group of 98 chronic renal disease patients treated solely with hemodialysis. Clinically significant red cell antibodies were formed in only 6.1% of transfused patients, and only 1 patient formed more than one antibody. We do not recommend extended red cell phenotyping, beyond ABO and Rh(D), in patients with end-stage renal disease who may require transfusion.
Volume
48
Issue
4
First Page
284
Last Page
285
ISSN
1660-8151
Published In/Presented At
Domen, R. E., & Ramirez, G. (1988). Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis. Nephron, 48(4), 284–285. https://doi.org/10.1159/000184943
Disciplines
Medicine and Health Sciences
PubMedID
3362273
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article
COinS